Topics tagged FDA

Topic	Replies	Views	Activity
🇺🇸 FDA Control of Nitrosamine Impurities in Human Drugs revision2 Guidance, Documents, Resources FDA	54	4170	May 4, 2025
📅 Updates on Approaches to Acceptable Intakes of Nitrosamine Drug Substance Related Impurities (NDSRIs) and Bioequivalence Assessment for Reformulated Drug Products(CRCG) Events / Workshops / Webinars NDSRI , FDA	39	3257	May 2, 2025
US FDA- Generic Drug Science and Research Priority Initiatives for Fiscal Year (FY) 2024 Nitrosamines in the News FDA	1	494	May 1, 2025
🕵🏻 OTC Market Withdrawal of Diphenhydramine Nitrosamines in the News NDSRI , FDA	0	228	April 24, 2025
FDA Generic Drugs Forum - Bioequivalence Approaches Events / Workshops / Webinars FDA , featured	2	459	April 22, 2025
N-nitroso-esmolol Limits of Nitrosamines NDSRI , FDA	0	81	April 22, 2025
Generic Drugs Forum (GDF) 2025 Events / Workshops / Webinars FDA	5	832	April 19, 2025
:brazil: Lhasa Brazil Symposium: Aligning Pharma & Regulatory Standards Globally :brazil: Events / Workshops / Webinars risk-assessment , FDA , NDSRI	0	118	April 3, 2025
US FDA declines to approve Milestone's heart rhythm nasal spray; shares halve Nitrosamines in the News FDA	0	164	March 28, 2025
CDER Drug Safety Priorities Fiscal Year 2023 Guidance, Documents, Resources FDA	2	646	February 27, 2025
Impact of Antioxidant Excipients on N-nitrosamine Formation and Bioequivalence in Metformin Formulations - Pub New Scientific Knowledge & Development risk-assessment , Excipients , FDA	3	571	February 11, 2025
👨‍💻 FDA-CRCG NDSRI Workshop Events / Workshops / Webinars FDA , CRCG	2	1455	January 10, 2025
CHPA's response to the Control of Nitrosamine Impurities in Human Drugs rev.2 Guidance, Documents, Resources FDA	1	378	January 2, 2025
Requirement after reformulation of existing approved drug product for Europe New Scientific Knowledge & Development EMA , FDA	12	386	November 12, 2024
Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program New Scientific Knowledge & Development Packaging , FDA	6	457	October 2, 2024
FDA-CDER and HESI \| Nitrosamine Ames Data Review and Method Development Workshop Events / Workshops / Webinars FDA	1	264	September 17, 2024
🇺🇸 FDA - Updated information on recommended AI for NDSRIs (23/Feb/2024) - Tables 2 & 3 Limits of Nitrosamines Limits , FDA , NDSRI	16	3878	July 28, 2024
Pharmaceutical industry wants FDA to extend deadline for testing novel nitrosamines Nitrosamines in the News FDA , NDSRI	3	1172	July 21, 2023
AI Limit for Nitroso Nebivolol Limits of Nitrosamines FDA , Drug_Substance_APIs , Storage_Stability , Manufacturing , Live-Conversations	11	2753	April 3, 2024
Nitrosamine requirements for probiotics Guidance, Documents, Resources FDA	4	357	February 12, 2024
N-nitroso Vonoprazan AI 96 ng/day- FDA Limits of Nitrosamines FDA	5	3614	January 29, 2024
A quick (dumb) question Limits of Nitrosamines FDA , Excipients	10	1198	January 22, 2024
AI for NDSRIs with positive EAT and/or in-vivo mutagenicity study - FDA position? Limits of Nitrosamines Limits , FDA , NDSRI	2	660	November 9, 2023
N-Nitroso desmethyl bedaquiline Limits of Nitrosamines FDA	0	665	October 6, 2023
Total impurities limit if more than one nitrosamine impurities are observed in product Limits of Nitrosamines Manufacturing , NDSRI , Drug_Substance_APIs , FDA , Live-Conversations	4	682	August 14, 2023
FDA Workshop: Mitigation Strategies for Nitrosamine Drug Substance Related Impurities Events / Workshops / Webinars Excipients , FDA , NDSRI , Drug_Substance_APIs , Manufacturing	11	3745	July 27, 2023
Fiscal Year (FY) 2023 Generic Drug Science and Research Initiatives Public Workshop May 11-12, 2023 Events / Workshops / Webinars FDA	3	627	June 15, 2023
FDA/HESI Collaborative Roadmap: Advancing Hazard and Risk Assessment of Nitrosamine Impurities in Pharmaceuticals Limits of Nitrosamines NDSRI , ames , FDA , Drug_Substance_APIs	2	925	June 5, 2023
N-nitroso Des-methyl Dapoxetine Limits of Nitrosamines FDA , Manufacturing , Drug_Substance_APIs	12	1245	May 31, 2023
FDA Revisiting the mutagenicity and genotoxicity of N-nitroso propranolol in bacterial and human in vitro assays Limits of Nitrosamines FDA , NDSRI , ames , NDSRIs	1	1544	May 24, 2023